Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients.
Gamma-aminobutyric acid (G.A.B.A.) was measured in the nucleus accumbens and thalamus of brains from patients who had died with schizophrenia or Huntington's chorea (H.C.) and from control subjects. Mean G.A.B.A. content was significantly reduced in both brain areas in schizophrenia and in H.C. Extraneous factors, such as age, interval from death to necropsy, cause of death, and drug use, did not readily explain the observed reduction in brain G.A.B.A. G.A.B.A. deficiency may be a biochemical characteristic of some forms of schizophrenia.
D001923:Brain Chemistry; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D009714:Nucleus Accumbens / Q000032:analysis / Q000378:metabolism* / Q000473:pathology; D012559:Schizophrenia / Q000378:metabolism* / Q000473:pathology; D012686:Septal Nuclei / Q000378:metabolism*; D013788:Thalamus / Q000032:analysis / Q000378:metabolism* / Q000473:pathology; D005680:gamma-Aminobutyric Acid / Q000032:analysis / Q000172:deficiency*
D005680:gamma-Aminobutyric Acid